Quick Answer
HeartSciences Inc. reported Operating Income of -$8.35 million for fiscal year 2025.
HeartSciences Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$8.35M | -32.5% |
| 2024 | -$6.31M | -3.2% |
| 2023 | -$6.11M | -29.8% |
| 2022 | -$4.71M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$1.93M | +18.7% | +7.0% |
| October 31, 2025 | -$2.07M | -4.5% | -10.6% |
| July 31, 2025 | -$1.87M | +9.7% | +21.0% |
| January 31, 2025 | -$2.37M | -55.5% | -19.5% |
| October 31, 2024 | -$1.99M | -26.4% | +4.4% |
| July 31, 2024 | -$2.08M | -56.0% | -36.1% |
| January 31, 2024 | -$1.53M | -16.5% | +2.8% |
| October 31, 2023 | -$1.57M | +11.5% | -18.0% |
- HeartSciences Inc. showed a decrease of -32.5% in Operating Income compared to the prior fiscal year.
- Over the 2022–2025 period, HeartSciences Inc.’s operating income has declined by 77.4% (from -$4.71 million to -$8.35 million).
- The most recent figure is from HeartSciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: